Loading...
Docoh
Log in Free sign up

Hypertension Diagnostics (HDII)

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries. The company was founded by Jay N. Cohn and Stanley M. Finkelstein on July 19, 1988 and is headquartered in Minneapolis, MN.

Company profile

Ticker
HDII
Exchange
OTC
Website
www.hypertensiondiagnostics.com
Employees
Incorporated
Minnesota
Location
Ontario, Canada
Fiscal year end
Dec 31
Sector
Health Technology > Biotechnology
Industry (SIC)
Surgical & Medical Instruments & Apparatus
3M • Boston Scientific • Baxter International • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences ...
SEC CIK
0001058828
Corporate docs
IRS number
411618036

HDII stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

14 Nov 19
16 May 22
31 Dec 22

Institutional ownership, Q3 2021

HDII institutional ownership history Ownership history
0.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 1 0 NEW
Opened positions 1 0 NEW
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 1K 0 NEW
Total shares 30K 0 NEW
Total puts 0 0
Total calls 0 0
Total put/call ratio – – –
Largest owners Shares Value Change
Triumph Capital Management 30K $1K NEW
Largest transactions Shares Bought/sold Change
Triumph Capital Management 30K +30K NEW
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
6th grade Avg
Removed: March
From filing 10-Q 2019 Q3
Financial reports
View all
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
19 Sep 19
10-Q
2019 Q1
Quarterly report
19 Sep 19
10-K
2018 FY
Annual report
18 Sep 19
10-K
2017 FY
Annual report
18 Sep 19
10-Q
2013 Q3
Quarterly report
14 May 13
10-Q
2013 Q2
Quarterly report
13 Feb 13
10-Q
2013 Q1
Quarterly report
13 Nov 12
10-K/A
2012 FY
Annual report (amended)
25 Oct 12
10-K
2012 FY
Annual report
27 Sep 12
Current reports
View all
8-K
Changes in Control of Registrant
6 Sep 19
8-K
Entry into a Material Definitive Agreement
15 Oct 13
8-K
Departure of Directors or Certain Officers
17 Sep 13
8-K
Other Events
8 Apr 13
8-K
Entry into a Material Definitive Agreement
6 Feb 13
8-K
Unregistered Sales of Equity Securities
2 Jan 13
8-K
Other Events
6 Jun 12
8-K
Other Events
2 Apr 12
8-K
Entry into a Material Definitive Agreement
26 Sep 11
8-K
Entry into a Material Definitive Agreement
30 Aug 11
Registration and prospectus
View all
RW
Registration withdrawal request
17 Jan 20
15-12G
Securities registration termination
10 Jun 14
D
$833.6K in debt / options, sold $833.6K, 14 investors
11 Mar 12
S-8
Registration of securities for employees
21 Aug 06
REGDEX/A
Notice of sale of securities (amended)
4 Sep 03
REGDEX
Notice of sale of securities
18 Aug 03
RW
Registration withdrawal request
30 Mar 03
S-3
Shelf registration
14 Nov 02
424B3
Prospectus supplement
20 Oct 02
424B3
Prospectus supplement
12 Sep 02
Proxies
View all
DEF 14C
Information statement
11 Nov 03
PRE 14C
Preliminary information
29 Sep 03
DEFA14A
Additional proxy soliciting materials
20 Oct 02
DEFA14A
Additional proxy soliciting materials
3 Oct 02
DEF 14A
Definitive proxy
6 Aug 02
PRE 14A
Preliminary proxy
29 May 02
DEF 14A
Definitive proxy
5 Nov 01
DEF 14A
Definitive proxy
6 Nov 00
DEF 14A
Definitive proxy
26 Oct 99
DEF 14A
Definitive proxy
29 Oct 98
Other
View all
UPLOAD
Letter from SEC
27 Feb 20
CORRESP
Correspondence with SEC
12 Feb 20
CORRESP
Correspondence with SEC
4 Feb 20
UPLOAD
Letter from SEC
16 Dec 19
UPLOAD
Letter from SEC
14 Apr 10
CORRESP
Correspondence with SEC
29 Mar 10
UPLOAD
Letter from SEC
14 Mar 10
UPLOAD
Letter from SEC
4 Feb 08
CORRESP
Correspondence with SEC
27 Jan 08
UPLOAD
Letter from SEC
13 Jan 08
Ownership
SC 13D
HYPERTENSION DIAGNOSTICS / BRIMMER KENNETH WILLIAM ownership change
20 Feb 12
SC 13D
HYPERTENSION DIAGNOSTICS / COHN JAY N MD ownership change
10 Feb 11
SC 13D
HYPERTENSION DIAGNOSTICS / STERN ALAN ownership change
10 Feb 11
SC 13D
HYPERTENSION DIAGNOSTICS / LEITNER LARRY ownership change
10 Feb 11
144
Notice of proposed sale of securities
23 Feb 04
144
Notice of proposed sale of securities
16 Nov 03
144
Notice of proposed sale of securities
12 Aug 03
144
Notice of proposed sale of securities
23 Apr 03